Active Public Health & Healthcare Infection & Immunity

Funding for CEPI 2.0’s next five-year business cycle 2022-2027

In plain English

AI plain-English summary

A global vaccine development organisation is preparing for the next pandemic before it arrives. This matters because the COVID-19 pandemic exposed how fragile the world’s response to novel pathogens really is. When a new virus emerges, the gap between identifying the threat and delivering a working vaccine to everyone who needs it can stretch into years, leaving millions vulnerable. CEPI’s work addresses that gap by building a system that does not start from scratch each time. If this succeeds, the world will no longer rely on ad hoc emergency measures during outbreaks. Instead, pre-agreed rules for financing, allocating, and distributing vaccines will be in place before a crisis hits. That means faster development of countermeasures against known threats like Ebola or Lassa fever, and a transformed ability to respond to entirely new pathogens. The quiet infrastructure that matters here is not roads or power grids, but the governance and collaboration networks that decide who gets a vaccine and when. Without that invisible system, even the best science cannot ensure equitable access.

View original technical description
CEPI’s 2022-2027 strategic priorities are founded on the three pillars of Prepare, Transform and Connect. CEPI will prepare for known epidemics and pandemic threats by developing vaccines and promising biologics against the most prominent known threats, building on COVID-19 achievements and CEPI 1.0. CEPI will transform the response to the next novel threat by harnessing innovations in technology and systems to significantly reduce the global vulnerability to threats from novel pathogen outbreaks. CEPI will enhance and expand global collaboration by connecting emerging infectious disease stakeholders to enable rapid countermeasure development, effective response and equitable access for those in need. If the products developed with CEPI’s funding are to realise their potential, they should flow through a system with pre-agreed governance, financing, allocation, and distribution mechanisms to govern their ultimate use. CEPI is already contributing to and helping shape a post-pandemic consensus, creating a well-prepared ecosystem able to react quickly without leaving anyone behind.

View the original record at the funder ↗

Researchers

Richard Hatchett IV (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Combatting Covid 19 Variant
Developing an Evidence Generation Platform for Therapeutics with a focus on Low and Middle Income Countries (LMICs)
Pandemic Preparedness: Analytical Capacity and Funding Tracking programme (Pandemic PACT): Wellcome Funding Proposal
Innovation and Complentary Capabilities for Vaccines
MRC Centre for Global Infectious Disease Analysis

Original classification

Discretionary Award - Vaccines

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.